Skip to main content
. 2015 Jul 22;37(1):239–251. doi: 10.1007/s13277-015-3686-6

Fig. 5.

Fig. 5

miR-495 suppresses the growth of endometrial cancer through the downregulation of FOXC1 in vivo. a The average volume of the tumour nodules derived from AN3CA and KLE cells that were stably expressed miR-495 in SCID mice. b The nodules obtained from the cancer cells injected subcutaneously into the flanks of nude mice. c, d qRT-PCR and western blot assay were performed to evaluate the expression levels of miR-495 (c) and FOXC1 (d) in the tumour nodules (*p < 0.05)